tiprankstipranks
Accelerate Diagnostics (AXDX)
NASDAQ:AXDX
US Market

Accelerate Diagnostics (AXDX) Financial Statements

Compare
300 Followers

Accelerate Diagnostics Financial Overview

Accelerate Diagnostics's market cap is currently $27.80M. The company's EPS TTM is $-2.722; its P/E ratio is ―; Accelerate Diagnostics is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 12.06M$ 12.75M$ 11.78M$ 11.16M$ 9.30M
Gross Profit$ 2.55M$ 3.30M$ -381.00K$ 4.46M$ 4.40M
Operating Income$ -54.03M$ -62.80M$ -71.56M$ -63.70M$ -72.83M
EBITDA$ -49.77M$ -55.80M$ -59.59M$ -59.66M$ -67.56M
Net Income$ -61.62M$ -62.49M$ -77.70M$ -78.21M$ -84.31M
Balance Sheet
Cash & Short-Term Investments$ 13.22M$ 45.56M$ 63.62M$ 68.27M$ 108.45M
Total Assets$ 31.37M$ 65.02M$ 83.05M$ 93.42M$ 134.42M
Total Debt$ 39.22M$ 77.54M$ 111.11M$ 149.98M$ 134.07M
Net Debt$ 27.08M$ 42.63M$ 71.22M$ 114.20M$ 73.06M
Total Liabilities$ 51.25M$ 87.28M$ 118.12M$ 156.24M$ 141.80M
Stockholders' Equity$ -19.89M$ -22.26M$ -35.07M$ -62.81M$ -7.38M
Cash Flow
Free Cash Flow$ -41.23M$ -49.28M$ -47.93M$ -51.76M$ -65.12M
Operating Cash Flow$ -40.20M$ -48.73M$ -47.32M$ -50.39M$ -64.79M
Investing Cash Flow$ 8.66M$ 12.42M$ 8.30M$ 13.61M$ 52.81M
Financing Cash Flow$ 9.02M$ 31.63M$ 43.23M$ 11.63M$ 6.82M
Currency in USD

Accelerate Diagnostics Earnings and Revenue History

Accelerate Diagnostics Debt to Assets

Accelerate Diagnostics Cash Flow

Accelerate Diagnostics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis